HIGHLIGHTS
- who: Carlos King Ho Wong from the Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China have published the article: Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study, in the Journal: (JOURNAL)
- what: The major advantage of this study design is the ability to control for the fixed confounders and time-invariant confounding that possibly vary between individuals, such as socioeconomic factors and genetic factors . The study provided . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.